Back to Journals » Psoriasis: Targets and Therapy » Volume 8

Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date

Total article views   HTML views PDF downloads Totals
11,437 Dovepress* 9,156+ 1,370 10,526
PubMed Central* 2,281 407 2,688
Totals 11,437 1,777 13,214
*Since 29 August 2018

View citations on PubMed Central and Google Scholar